Blackford joins Cortechs.ai to provide workflow automation, efficiency improvements, and advance medical standards while improving patient outcomes and reducing care costs.
(SAN DIEGO) Aug. 9, 2018 – Cortechs.ai, a leader in brain imaging analysis technology, announced it has partnered with Blackford Analysis to offer its software through Blackford’s single marketplace platform. The partnership will provide Blackford clients with access to NeuroQuant and LesionQuant, fully automated segmentation applications for the evaluation of brain structure volume changes relevant to neurodegenerative diseases.
Customers will receive the same fast and easy imaging and report processing as a direct Cortechs.ai customer along with the objective and reproducible brain structure volumes and normative percentiles to aid in diagnosing and monitoring of disease progression and treatment outcomes in patients with neurodegenerative disorders.
Intelerad, a leading enterprise workflow solutions provider and partner of Blackford will now be able to utilize this technology through their platform. Through its user interface tool “Inteleviewer,” Intelerad can access Cortechs.ai’ imaging application and achieve a new, simplified and quick approach to image analysis. Condition-specific, actionable information enables healthcare professionals to achieve better patient outcomes and improve diagnostic confidence.
“We are pleased to partner with Blackford,” said Dr. Chris Airriess, COO of Cortechs.ai. “NeuroQuant has become the standard for brain volume measurements, and this partnership will expand quantitative neurological imaging by making it even easier to integrate into clinical workflows.”
The partnership provides Cortechs.ai with an extended network of healthcare and medical imaging providers as well as added value for Blackford’s all-in-one marketplace platform. Cortechs.ai cloud-based technology also allows Blackford Analysis to sync new software updates as they are released, providing users with the latest and most up-to-date reports. Cortechs.ai and Blackford Analysis look to continue their partnership through the improvement and advancement of automation and neuroimaging technology.
About Blackford
Blackford provides a single platform to quickly access and manage a curated marketplace of regulatory approved medical image analysis applications and AI algorithms that add clinical value. Easily integrated into existing workflows, the platform provides actionable information that allows healthcare providers to use imaging information smartly and reduce the cost of care, while improving diagnostic confidence and patient outcomes. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by TRI Cap, Old College Capital, and Archangel Investors, one of the UK’s leading business angel syndicates. For more information, visit www.blackfordanalysis.com
About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and brain development abnormalities. Please visit cortechs.ai for further information.
###
Contact: Travis Foegler
Phone: +1 (619) 450-9094
Email: Tfoegler@cortechs.ai
